Results of a phase I/II clinical trial: Standardized, non-xenogenic, cultivated limbal stem cell transplantation

Journal of Translational Medicine

Volumn 12, Issue 1, 2014, Pages

  Zakaria, Nadia ^a   Possemiers, Tine ^a   Dhubhghaill, Sorcha N ^a   Leysen, Inge ^a   Rozema, Jos ^a   Koppen, Carina ^a   Timmermans, Jean Pierre ^b   Berneman, Zwi ^a   Tassignon, Marie Jose ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Amniotic membrane; Cell culture; Cell transplantation; Cellular therapy; Clinical trial; CNT 20; Composite grafts; Corneal neovascularization; Corneal opacity; Corneal reconstruction; Limbal epithelial stem cells; Limbal stem cell transplantation; Ocular surface reconstruction; Progenitor cells; SHEM; Somatic stem cells; Tissue regeneration; Tissue specific stem cells

Indexed keywords

5' NUCLEOTIDASE; ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; AGENTS ACTING ON THE EYE; AUTOLOGOUS SERUM DROPS; BETA1 INTEGRIN; CD14 ANTIGEN; CD227 ANTIGEN; CD45 ANTIGEN; CYCLOSPORIN A; LEUKOCYTE ANTIGEN; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; OFLOXACIN; PREDNISOLONE; THY 1 ANTIGEN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CHILD; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORNEA NEOVASCULARIZATION; CORNEA OPACITY; EPITHELIUM CELL; EXPLANT; EYE BIOPSY; EYE DISEASE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LIMBAL STEM CELL DEFICIENCY; LIMBAL STEM CELL TRANSPLANTATION; MALE; MIDDLE AGED; PAIN; PATIENT SAFETY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHENOTYPE; PHOTOPHOBIA; PRESCHOOL CHILD; PROTEIN EXPRESSION; SEX DIFFERENCE; STANDARDIZATION; TREATMENT FAILURE; VISUAL ACUITY; XENO-FREE CULTURE;

ADOLESCENT; ADULT; AGED; AMNION; ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; CHILD; CORNEAL DISEASES; EPITHELIAL CELLS; FEMALE; FLOW CYTOMETRY; HUMANS; LIMBUS CORNEAE; MALE; MIDDLE AGED; POSTOPERATIVE CARE; PREOPERATIVE CARE; REPRODUCIBILITY OF RESULTS; STEM CELL TRANSPLANTATION; STEM CELLS; TRANSPLANTATION, HETEROLOGOUS; TREATMENT OUTCOME; VISUAL ACUITY; YOUNG ADULT;

EID: 84899493515     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-12-58     Document Type: Article

References (34)

1. Puangsricharern V, Tseng SC. Cytologic evidence of corneal disease with limbal stem cell deficiency. Ophthalmology 1995, 102:1476-1485. 10.1016/S0161-6420(95)30842-1, 9097795.
2. Rumelt S, Bersudsky V, Blum-Haruveni T, Rehany U. Systematic cyclosporing A in high failure risk, repeated corneal transplantation. Br J Ophthalmol 2002, 86:988-992. 10.1136/bjo.86.9.988, 1771260, 12185123.
3. Holland E. Epithelial transplantation for the management of severe ocular surface disease. Trans Am Ophthalmol Soc 1996, 94:677-743. 1312113, 8981714.
4. Shimmura S, Tsubota K. Surgical treatment of limbal stem cell deficiency: are we really transplanting stem cells?. Am J Ophthalmol 2008, 146:154-155. 10.1016/j.ajo.2008.04.025, 18656582.
5. Daya S, Watson A, Sharpe JR, Giledi O, Rowe A, Martin R, James SE. Outcomes and DNA analysis of ex vivo expanded stem cell allograft for ocular surface reconstruction. Ophthalmology 2005, 112:470-477. 10.1016/j.ophtha.2004.09.023, 15745776.
6. Kolli S, Ahmad S, Lako M, Figueiredo F. Successful clinical implementatio of corneal epithelial stem cell therapy for treatment of unilateral stem cell deficiency. Stem Cells 2010, 28:597-610.
7. Nakamura T, Inatomi T, Sotozono C, Ang LP, Koizumi N, Yokoi N, Kinoshita S. Transplantation of autologous serum-derived cultivated corneal epithelial equivalents for the treatment of severe ocular surface disease. Ophthalmology 2006, 113:1765-1772. 10.1016/j.ophtha.2006.04.030, 16905193.
8. Pauklin M, Fuchsluger TA, Westekemper H, Steuhl KP, Meller D. Midterm results of cultivated autologous and allogenic limbal epithelial transplantation in limbal stem cell deficiency. Dev Ophthalmol 2010, 45:57-70.
9. Rama P, Matuska S, Paganoni G, Spinelli A, De LM, Pellegrini G. Limbal stem-cell therapy and long-term corneal regeneration. N Engl J Med 2010, 363:147-155. 10.1056/NEJMoa0905955, 20573916.
10. Sangwan A, Secker GA, Rajan MS, Melingonis G, Dart JK, Tuft SJ, Daniels JT. Ex vivo expansion and transplantation of limbal epithelial stem cells. Ophthalmology 2008, 115:1989-1997. 10.1016/j.ophtha.2008.04.039, 18554721.
11. Sangwan A, Matalia HP, Vemuganti GK, Fatima A, Ifthekar G, Singh S, Nutheti R, Rao GN. Clinical outcome of autologous cultivated limbal epithelium transplantation. Indian J Ophthalmology 2006, 54:29-34.
12. Koizumi N, Inatomi T, Suzuki T, Sotozono C, Kinoshita S. Cultivated corneal epithelial stem cell transplantation in ocular surface disorders. Ophthalmology 2001, 108:1569-1574. 10.1016/S0161-6420(01)00694-7, 11535452.
13. Shimazaki J, Higa K, Morito F, Dogru M, Kawakita T, Satake Y, Shimmura Y, Tsubota K. Factors influencing outcomes in cultivated limbal epithelial transplantation for chronic cicatricial ocular surface disorders. Am J Ophthalmol 2007, 143:945-953. 10.1016/j.ajo.2007.03.005, 17459317.
14. Sangwan V. Basu Sm Vemuganti GK et al. Clinical outcomes of xeno-free autologous cultivated limbal epithelial transplantation: a 10-year study. Br J Ophthalmol 2011, 95:1525-1529. 10.1136/bjophthalmol-2011-300352, 21890785.
15. Zakaria N, Koppen C, Van Marck V, Berneman Z, Hopkinson A, Tassignon MJ. Standardized limbal epithelial stem cell graft generation and transplantation. Tissue Eng Part C: Methods 2010, 16:921-927. 10.1089/ten.tec.2009.0634, 19916804.
16. Donisi P, Rama P, Fasolo A, Ponzin D. Analysis of limbal stem cell deficiency be corneal impression cytology. Cornea 2003, 22:533-538. 10.1097/00003226-200308000-00009, 12883346.
17. Schulze-Bonsel KF,F, Burau H, Hansen L, Bach M. Visual acuities " hand motion" and " counting fingers" can be quantified with the Freiburg Visual Acuity Test. Invest Ophthalmol Vis Sci 2006, 47:1236-1240. 10.1167/iovs.05-0981, 16505064.
18. Flaherty S. Pain measurement tools for clinical practice and research. AANA J 1996, 64:133-140.
19. Hopkinson A, McIntosh RS, Tighe PJ, James DK, Dua HS. Amniotic membrane for ocular reconstruction: donor variation and the effect of handling on TGF-beta content. Invest Ophthalmol Vis Sci 2006, 47:4316-4322. 10.1167/iovs.05-1415, 17003421.
20. Hopkinson A, Shanmuganathan VA, Gray T, Yeung AM, Lowe J, James DK, Dua HS. Optimization of amniotic membrane denuding for tissue engineering. Tissue Eng Part C: Methods 2008, 14:371-381. 10.1089/ten.tec.2008.0315, 18821842.
21. Zakaria N, Van GS, Wouters K, Rozema J, Koppen C, Lion E, Cools N, Berneman Z, Tassignon MJ. Human tears reveal insights into corneal neovascularization. PLoS One 2012, 7:e36451. 10.1371/journal.pone.0036451, 3348927, 22590547.
22. Schallmoser K, Rohde E, Reinisch A, Bartmann C, Thaler D, Drexler C, Obenauf AC, Lanzer G, Linkesch W, Strunk D. Rapid large-scale expansion of functional mesenchymal stem cells from unmanipulated bone marrow without animal serum. Tissue Eng Part C: Methods 2008, 14:185-196. 10.1089/ten.tec.2008.0060, 18620484.
23. Report. U.S. Department of Health and Human Services Food and Drug Administration (FDA) centre for biologics evaluation and research (CBER). Information for recommendations for physicians involved in the co-culture of human embryos with nonhuman animal cells 2000, Rockville MD: US (FDA) Report, Report. U.S. Department of Health and Human Services.
24. Martin M, Muotri A, Gage F, Varki A. Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nat Med 2005, 11:228-232. 10.1038/nm1181, 15685172.
25. Lekhanont K, Choubtum L, Chuch RS, Sangiampornpanit T, Chuchpaiwong V, Vongthongsri A. A serum and feeder-free technique of culturing human corneal epithelial stem cells on amniotic membrane. Mol Vis 2009, 15:1294-1302. 2704912, 19578552.
26. Gstraunthaler G. Alternatives to the use of fetal bovine serum. ALTEX 2003, 20:275-281.
27. Shortt A, Secker CA, Notara MD, Limb GA, Khaw PT, Tuft SJ, Daniels JT. Transplantation of ex vivo cultured limbal epithelial stem cells: a review of techniques and clinical results. Surv Ophthalmol 2007, 52:371-379.
28. Panda A, Kumar S, Kumar A, Bansal R, Bhartiya S. Fibrin glue in ophthalmology. Indian J Ophthalmology 2009, 57:371-379.
29. Nassiri N, Pandya HK, Djalillian AR. Limbal allograft transplantation using fibrin glue. Arch Ophthalmol 2011, 129:218-222.
30. Takaoka M, Nakamura T, Sugai H, Bentley AJ, Nakajima N, Yokoi N, Fullwood. Novel sutureless keratoplasty with chemically defined bioadhesive. Invest Ophthalmol Vis Sci 2009, 50:2679-2685. 10.1167/iovs.08-2944, 19136714.
31. Shortt AJTS, Daniels JT. Ex vivo cultured limbal epithelial transplantation: a clinical perspective. Ocul Surf 2010, 8:80-90. 10.1016/S1542-0124(12)70072-1, 20427011.
32. Ni Dhubhghaill S, Rozema JJ, Jongenelen S, Ruiz Hidalgo I, Zakaria N, Tassignon MJ. Normative values for corneal densitometry analysis by scheimpflug optical assessment. Invest Ophthalmol Vis Sci 2014, 55:162-168. 10.1167/iovs.13-13236, 24327608.
33. Hillenaar T, Cals RH, Eilers PH, Wubbels RJ, van Cleynenbreugel H, Remeijer L. Normative database for corneal backscatter analysis by in vivo confocal microscopy. Invest Ophthalmol Vis Sci 2011, 52:7274-7281. 10.1167/iovs.11-7747, 21849426.
34. Wang J, Simpson TL, Fonn D. Objective measurements of corneal light-backscatter during corneal swelling by optical coherence tomography. Invest Ophthalmol Vis Sci 2004, 45:3493-3498. 10.1167/iovs.04-0096, 15452054.